{"id":5977,"date":"2023-02-25T18:13:44","date_gmt":"2023-02-25T18:13:44","guid":{"rendered":"https:\/\/imsfund.com\/?p=5977"},"modified":"2023-02-25T18:13:44","modified_gmt":"2023-02-25T18:13:44","slug":"what-do-britains-scaleups-want-from-the-science-superpower-agenda","status":"publish","type":"post","link":"https:\/\/imsfund.com\/index.php\/2023\/02\/25\/what-do-britains-scaleups-want-from-the-science-superpower-agenda\/","title":{"rendered":"What Do Britain\u2019s Scaleups Want From The \u201cScience Superpower\u201d Agenda?"},"content":{"rendered":"<p> <br \/>\n<\/p>\n<div>\n<figure class=\"embed-base image-embed embed-0\" role=\"presentation\"><figcaption><fbs-accordion><\/p>\n<p class=\"color-body light-text\">Scott White, CEO of Pragmatic Semiconductor<\/p>\n<p><\/fbs-accordion><small>PragmatIC<\/small><\/figcaption><\/figure>\n<p>There\u2019s nothing a politician likes better than a mantra &#8211; a phrase that can be repeated again and again until, possibly, thought becomes reality.<\/p>\n<p>And one of the latest mantras to trip off the tongues of U.K. government ministers is \u201cscience superpower.\u201d It\u2019s been around for a while. In 2021, former Prime Minister, Boris Johnson said his government\u2019s aim was to restore Britain\u2019s place as a scientific superpower. More recently &#8211; at the end of 2023, to be precise &#8211; Finance Minister, Jeremy Hunt told members of parliament that his goal was to ensure the U.K. could rival Silicon Valley. This year, the Prime Minister reorganized the machinery of government and set up a Ministry for Science, Innovation and Technology. Naturally enough, startups and scaleups are expected to play a vital role in a flowering of commercially exploitable science.<\/p>\n<p>So how skeptical should we be? It\u2019s tempting to think of the science superpower agenda as a kind of figleaf for a government at a time when the wider economy isn\u2019t looking particularly healthy.<\/p>\n<p>That would be overly cynical. For one thing, the U.K. tech sector is performing pretty well. It continues to attract high levels of foreign and domestic VC cash. In the first half of 2022,<a href=\"https:\/\/www.uktech.news\/news\/industry-analysis\/uk-vc-investment-2022-20230118#:~:text=In%20the%20first%20half%20of,along%20with%20health%20and%20biotech.\" target=\"_blank\" class=\"color-link\" title=\"https:\/\/www.uktech.news\/news\/industry-analysis\/uk-vc-investment-2022-20230118#:~:text=In%20the%20first%20half%20of,along%20with%20health%20and%20biotech.\" rel=\"nofollow noopener noreferrer\" data-ga-track=\"ExternalLink:https:\/\/www.uktech.news\/news\/industry-analysis\/uk-vc-investment-2022-20230118#:~:text=In%20the%20first%20half%20of,along%20with%20health%20and%20biotech.\" aria-label=\"\u00a314.7.7 billion\"> \u00a314.7.7 billion<\/a> of VC capital flowed into Britain. And although investment dropped sharply to \u00a38 billion between July and December, the U.K. tech sector is still a magnetfor capital. Perhaps more importantly, it\u2019s important economically for the U.K. to ensure that it is not left behind in the commercial development of key technologies. So no one should argue with the ambition.<\/p>\n<p>But as Science Minister George Freeman has acknowledged, Britain is not yet a science superpower but rather &#8211; in his words &#8211; a \u201cscience powerhouse.\u201d Achieving the former status would involve becoming an \u201cinnovation nation.\u201d Essentially what he meant was creating an environment in which scientific research could be successfully industrialized.<\/p>\n<p>How can that be achieved? I spoke to two scaleup CEOs at the heart of the science and technology sector to get their take on the measures required to support their industries.<\/p>\n<p>Scott White is CEO of Pragmatic<a href=\"https:\/\/www.pragmaticsemi.com\/\" target=\"_blank\" class=\"color-link\" title=\"https:\/\/www.pragmaticsemi.com\/\" rel=\"nofollow noopener noreferrer\" data-ga-track=\"ExternalLink:https:\/\/www.pragmaticsemi.com\/\" aria-label=\"Semiconductor\"> Semiconductor<\/a>. Founded twelve years ago, it has developed a microchip technology that doesn\u2019t require silicon. Today, it produces low-cost and flexible chips that can be used in multiple contexts. Its business model revolves around manufacturing &#8211; with a facility in the North East of England &#8211; but also plans to offer compact manufacturing equipment to customers. In addition, it designs its own RFID chips for tracking goods in transit.<\/p>\n<p><fbs-ad position=\"inread\" progressive=\"\" ad-id=\"article-0-inread\" aria-hidden=\"true\" role=\"presentation\"\/><\/p>\n<p>Pragmatic has just commissioned a poll of 250 technology business leaders. When asked whether the government could meet its objective of being a science superpower by 2030, a healthy 68 per cent yes but only 40 per cent thought enough government support was on offer.<\/p>\n<p><strong>Unbalanced Investment<\/strong><\/p>\n<p>As White sees it, the UK\u2019s cash-rich ecosystem remains unbalanced, with much of the funding going to early-stage businesses, rather than scaleups. Most of the capital that is invested at later stages comes from overseas. \u201cWe did a Series C in 2021, 2022- that was for $125 million. Eighty per cent of the investment came from outside of the UK,\u201d he says.<\/p>\n<p>So in that respect, there is a need for capital that will allow tech businesses to remain in the UK in terms of both location and control as they grow.<\/p>\n<p>But what can the government actually do? Well, one way forward is to make it easier for institutions to invest. White welcomes changes to insurance industry regulation that will allow pension funds in particular to allocate money to tech.<\/p>\n<p>He also acknowledges the progress made in providing public funding through the <a href=\"https:\/\/www.british-business-bank.co.uk\/\" target=\"_blank\" class=\"color-link\" title=\"https:\/\/www.british-business-bank.co.uk\/\" rel=\"nofollow noopener noreferrer\" data-ga-track=\"ExternalLink:https:\/\/www.british-business-bank.co.uk\/\" aria-label=\"British Business Bank\">British Business Bank<\/a> and its venture arm, <a href=\"https:\/\/www.britishpatientcapital.co.uk\/\" target=\"_blank\" class=\"color-link\" title=\"https:\/\/www.britishpatientcapital.co.uk\/\" rel=\"nofollow noopener noreferrer\" data-ga-track=\"ExternalLink:https:\/\/www.britishpatientcapital.co.uk\/\" aria-label=\"British Patient Capital\">British Patient Capital<\/a>. In addition to investing alongside VCs, the organization has created Future Fund: Breakthrough, with \u00a3375 million earmarked for deep tech ventures. \u201cThat\u2019s good but the scale needs to be much bigger,\u201d says White.<\/p>\n<figure class=\"embed-base image-embed embed-1\" role=\"presentation\"><figcaption><fbs-accordion><\/p>\n<p class=\"color-body light-text\">Mostafa ElSayed, CEO and co-founder of Automata<\/p>\n<p><\/fbs-accordion><small>Automata<\/small><\/figcaption><\/figure>\n<p>Mostafa ElSayed agrees. He is CEO and co-founder of <a href=\"https:\/\/automata.tech\/\" target=\"_blank\" class=\"color-link\" title=\"https:\/\/automata.tech\/\" rel=\"nofollow noopener noreferrer\" data-ga-track=\"ExternalLink:https:\/\/automata.tech\/\" aria-label=\"Automata\">Automata<\/a>, a company that provides automation technology for laboratories, mainly in the life sciences sector. The company\u2019s products are designed to speed process such as diagnostics and clinical trials while cutting down on human error. He argues that some sectors are better served with others when capital is allocated by VCs, with deep tech having a particular problem. \u201cWe all talk about the importance of deep tech, but access to funding in the deep tech sector is hard.\u201d<\/p>\n<p>And the UK may be falling behind its European competitors. \u201cThe biggest backer of deep tech is <a href=\"https:\/\/www.bpifrance.com\/\" target=\"_blank\" class=\"color-link\" title=\"https:\/\/www.bpifrance.com\/\" rel=\"nofollow noopener noreferrer\" data-ga-track=\"ExternalLink:https:\/\/www.bpifrance.com\/\" aria-label=\"BPIFrance\">BPIFrance<\/a> (a sovereign wealth fund), after that its Germany and then Scandinavia,\u201d says ElSayed.<\/p>\n<p>ElSayed says change could be coming. He cites comments from the new head of the British Business Bank who recently floated the idea of creating a sovereign growth fund to support innovation.<\/p>\n<p>Relatively small changes could also deliver benefits. White points to existing programs, such as the Enterprise Investment Scheme(EIS) and Venture Capital Trusts. By offering tax breaks to those who back eligible companies, these vehicles have encouraged investors to back startups. However, once companies get to a certain size, the tax breaks fall away, meaning the schemes don\u2019t benefit scaleups.<\/p>\n<p><strong>Boosting Demand<\/strong><\/p>\n<p>It\u2019s not all about the money. \u201cThere is also a need to support domestic demand,\u201d says White. \u201cFor instance, you can use government procurement to drive adoption.\u201d<\/p>\n<p>Indeed, in some sectors, the government has a huge amount of power to make things happen. ElSayed, uses the example of clinical trials. The U.K. has a hugely important resource in the form of a National Health Service that serves more or less the whole population and can gather data accordingly.Potentially, this makes Britain one of the best countries in the world to carry out clinical trials. However, although a national service, much of the decision-making is at the level of local health trusts. \u201cThere needs to be a national strategy,\u201d says ElSayed. There is a precedent in that Britain already has a national strategy for genomics research.<\/p>\n<p>Another important piece of the jigsaw is visa policy. ElSayed stresses the need for a regime that allows science-based businesses to recruit quickly. \u201cWhen a company is moving at our pace, you struggle to find people who have the right to work in the UK,\u201d he says.<\/p>\n<p>Scott White says Britain has the potential to become a science superpower, but clarity is required around what that actually means. In terms of government support, the pieces of the jigsaw are not all in place.<\/p>\n<\/div>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.forbes.com\/sites\/trevorclawson\/2023\/02\/25\/mantra-or-reality-what-do-britains-scaleups-want-from-the-science-superpower-agenda\/\">Source link <\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Scott White, CEO of Pragmatic Semiconductor PragmatIC There\u2019s nothing a politician likes better than a mantra &#8211; a phrase that can be repeated again and again until, possibly, thought becomes reality. And one of the latest mantras to trip off the tongues of U.K. government ministers is \u201cscience superpower.\u201d It\u2019s been around for a while. [&hellip;]<\/p>\n","protected":false},"author":5,"featured_media":5978,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"default","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","ast-disable-related-posts":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"fifu_image_url":"https:\/\/imageio.forbes.com\/specials-images\/imageserve\/63f9ca68c1f61f6cae093b48\/0x0.jpg?format=jpg&crop=1963,1963,x882,y0,safe&width=1200","fifu_image_alt":"","footnotes":""},"categories":[9],"tags":[],"class_list":["post-5977","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"_links":{"self":[{"href":"https:\/\/imsfund.com\/index.php\/wp-json\/wp\/v2\/posts\/5977","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/imsfund.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/imsfund.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/imsfund.com\/index.php\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/imsfund.com\/index.php\/wp-json\/wp\/v2\/comments?post=5977"}],"version-history":[{"count":1,"href":"https:\/\/imsfund.com\/index.php\/wp-json\/wp\/v2\/posts\/5977\/revisions"}],"predecessor-version":[{"id":5979,"href":"https:\/\/imsfund.com\/index.php\/wp-json\/wp\/v2\/posts\/5977\/revisions\/5979"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/imsfund.com\/index.php\/wp-json\/wp\/v2\/media\/5978"}],"wp:attachment":[{"href":"https:\/\/imsfund.com\/index.php\/wp-json\/wp\/v2\/media?parent=5977"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/imsfund.com\/index.php\/wp-json\/wp\/v2\/categories?post=5977"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/imsfund.com\/index.php\/wp-json\/wp\/v2\/tags?post=5977"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}